Cre8 DES in diabetics: when innovation in drug elution technology is translated into empowered efficacy

With an unrestricted educational grant from Alvimedica Singapore

Chairpersons: J. Fajadet, M.A. Rosli
Speakers: J. Fajadet, J. Tan

Learning Objectives

  • To understand how, and in which way, to improve PCI clinical outcome in diabetic patients
  • To learn the added efficacy value provided by the Amphilimus eluting polymer free DES - Cre8
  • To review Cre8 clinical program and the latest results

Presentations available when logged in:

  • Session objectives
  • How the innovative Amphilimus formulation eluted from Cre8 empowers efficacy in diabetics
  • The latest Cre8 clinical evidence in diabetics confirms its enhanced efficacy in this cohort of patients
  • Key learnings